CRE Notice to FDA: TPSAC Violates FACA
CRE continues to identify FDA/TPSAC non-compliance with FACA. Would senior career civil servants who are charged with ensuring FACA compliance permit such actions for any products other than tobacco?
See the attached memorandum which explains in detail the reasons why the Constitutents Subcommitee is in violation of FACA. Hopefully, FDA will address these issues administratively so as not to necessiate other corrective actions.
CRE’s objective is to make FDA aware of its non-compliance with FACA so it will not make the same mistakes when it establshes the menthol subcommittee.
See CRE coverage in FDA Week
